INTRODUCTION
Mature lymphocytes migrate continuously among lymphoid organs via the blood and lymph vessels. Lymphocytes leave the blood by selectively adhering, binding to, and migrating through postcapillary high endothelium venules (HEV) in lymphoid organs. Two distinct lymphocyte-HEV recognition systems control homing of lymphocytes into lymphoid organs, one for peripheral lymph nodes (pLN) and one for mucosal lymphoid organs . Complementary molecules expressed on both the T-cell surface and the endothelium mediate tissue-specific endothelial-cell recognition. The first lymphocyte homing receptor identified is defined by the MEL-14 antibody, which blocks homing of lymphocytes into pLN (Gallatin et al., 1983) . Binding of mouse lymphocytes to Peyer's patch (PP) HEV is at least partly mediated by the integrins c4//1/o4//7 (LPAM-1/2)  *Corresponding author. . Other lymphocyte receptors involved in HEV recognition, such as the integrin LFA-1 or the molecule Pgp-1, are not organ-specific (Jalkanen et al., 1987; Hamann et al., 1988; Picker et al., 1989 ). Endothelial-cell-surface molecules involved in tissue-specific interactions with lymphocytes include addressins, Ig family molecules, and integrins (Springer, 1990;  Butcher, 1991; Shimisu et al., 1992) .
The differential expression of receptors/counter receptors regulates migration patterns of different lymphoid populations and determines their representation in particular regions. Such mechanisms are involved in the establishment of inflammation. HEV-like venules expressing vascular addressins are observed in target organs of autoimmune diseases associated with lymphocytic infiltration such as rheumatoid arthritis (Jalkanen et al., 1986; DintherJanssen et al., 1990) , EAE (Cannella et al., 1991) , and insulin-dependent diabetes mellitus (Berg et al., 1989) . The NOD mouse is an experimental model for human autoimmune type 1 diabetes, in which lymphocyte infiltration around and into the islets of Langerhans develops from 3-5 weeks of age in both sexes, whereas overt diabetes occurs predominantly in females from 12 weeks of age (Makino et al., 1980) . The central role of T cells in insulin-secreting beta-cell destruction has been widely documented (Miyazaki et al., 1985; Ogawa et al., 1985; Mori et al., 1986; Schizuru et al., 1988; Bendelac et al., 1987;  Semp6 et al., 1991). The mononuclear cell infiltrate is mostly composed of T cells with a minority of B lymphocytes and macrophages (Miyazaki et al., 1985 (Tochino, 1987) (Stevens et al., 1982; Pals et al., 1986; Westermann et al., 1989 ).
CD4 and CD8 T-Cell Subset Localization
The results, presented as relative migration indexes (RMI) in five different strains, show straindependent migration patterns of CD4 and CD8 subsets (Fig. 1) . In addition to tissue-specific T and B lymphocyte migration, T-cell subset-specific interactions with endothelium were observed. There is general agreement about these interactions in rats and sheep (Washington et In BALB/c mice, 3 to 5 times more CD4 than CD8 cells were found in the LN and PP. In this strain, CD4 and CD8 cells migrated with the same efficiency in the spleen. Lymphocyte homing to the spleen does not involve HEV, but the spleen has a predominant role in lymphocyte migration and thus was included in this study (Pabst, 1988 It has been suggested that nonrandom recirculation of CD4 and CD8 T cells could be explained by subset-specific adhesion molecules whose interaction with endothelial counterreceptors would determine the rate of extraction of lymphocyte subsets of a given tissue specificity (Washington et al., 1988; Abernethy et al., 1990) . On the other hand, straindependent differences may be related to the lymphocyte-subset representation, which is genetically controlled in inbred strains of mice (Kraal et al., 1983b) . Indeed, Kraal and colleagues (1983b) reported that CD8 cells constitute a significantly greater proportion of total T cells in C57BL/6 mice than in BALB/c mice, resulting in a higher CD4/ CD8 ratio in BALB/c than in C57BL/6. In this study, similar results were found. The CD4/CD8 ratio of LN cells was 1.4 + 0.1 in C57BL/6 mice versus 2.5 + 0.1 in BALB/c mice. In NOD mice, the CD4/CD8 ratio (2.7 + 0.2) was identical to that in BALB/c, and the greatest differences in the relative homing of CD4 and CD8 cells were observed in these two mouse strains.
To determine whether there was a correlation between the homing characteristics of CD4 and CD8 cells and the severity of insulitis, which increases with time, migration of these subsets was studied in NOD and BALB/c mice of different ages.
No major differences were observed between healthy adult (10 and 20 weeks) and diabetic NOD mice. However, in 2-week-old NOD, thus before insulitis develops, the migration of CD4 cells was hardly different from that of CD8 cells. On the contrary, no significant age-dependent differences were observed in BALB/c. Moreover, the RMI in the circulating blood of young and adult NOD mice were comparable, suggesting no difference in the blood transit time of CD4 and CD8 cells with the age of the mice. It would be interesting to determine whether the different migration patterns of the two T-cell subsets in 2-week-old and adult NOD mice may be associated with the pathogenesis of the disease. It is noteworthy that the development of the disease appears to depend upon cellular events taking place around weaning and that would be involved in the generation of suppressor T cells. Previous experiments showed that thymectomy at 3 weeks of age results in an increase in the incidence of diabetes, suggesting that suppressor mechanisms develop after that age (Dardenne et al., 1989) . This was supported by the fact that diabetes can be transfered into nonirradiated mice from birth until about 3 weeks of age (Bendelac et al., 1987) .
Lastly, no major differences in the expression of the MEL-14 antigen, LFA-1, and Pgp-1 could explain the different migratory properties of CD4 and CD8 cells in BALB/c, NOD and C57BL/6 mice. We confirm data from others showing higher expression of the MEL-14 antigen on CD8 cells than on CD4 cells in mice (Ohgama and OnoG 1992) , and a higher expression of Pgp-1 cells in BALB/c mice as compared to C57BL/6 mice (Lynch and Ceredig, 1989 were generously given by Dr. E.H. Leiter (Jackson Laboratory, Bar Harbor, ME). NOD mice were used at ages ranging from 2 to 25 weeks. BALB/c were used at 2 and 10 weeks of age and DBA/2, C57BL/ 6, CBA, and NOD Thy-l.1 at 10 weeks. Diabetic mice were used within the week following disease onset.
rat IgG) (Pierres et al., 1982) , Pgp-1 (IM7, rat IgG2b) (Trowbridge et al., 1982) , and the lymphocyte homing receptor rat The standard labeling procedures have been previously described 
